VP Business Development, Ultragenyx
Yael Weiss received her MD degree from Hadassah Medical School in Jerusalem, and her PhD in molecular genetics from the Weizmann Institute of Science in Rehovot, Israel. After working at Sheba Medical Center for several years Yael joined Columbine Ventures and then joined Genzyme Israel as director of Medical Affairs and Business Development.
In 2004, Yael joined Merck Sharp & Dohme Israel as Medical Director, a role in which she oversaw Merck’s clinical trials and supported the sales and marketing organizations. In 2007 Yael relocated to the SF B.ay Bay Area to take the position of Director, External Scientific Affairs and World Wide Licensing, West Coast. Her responsibilities focused on the identification and evaluation of novel licensing and scientific collaboration opportunities emanating from West Coast-based academic laboratories, biotechs and venture capital firms. Yael headed a group that evaluates the clinical, regulatory and safety aspects of Merck’s regional deals globally (including markets). Currently, Yael is VP of Business Development for Ultragenyx.